No registrations found.
ID
Source
Brief title
Health condition
Extrinsieke ureter obstructie
Extrinsic ureter obstruction
Sponsors and support
Haga Ziekienhuis
Leyweg 275
2545 CH Den Haag
070-2100000
h.voverhagen@hagaziekenhuis.nl
Intervention
Outcome measures
Primary outcome
Immediate technical success rate
Secondary outcome
• To compare VAS scores after retrograde and antegrade stent insertion in patients with extrinsic urinary tract obstruction.
• To compare the complications after retrograde and antegrade stent insertion in patients with extrinsic urinary tract obstruction.
• To compare technical success rates at 30 days after retrograde and antegrade stent insertion in patients with extrinsic urinary tract obstruction.
• To compare scores on EQ5D questionnaire at 30 days after retrograde and antegrade stent insertion in patients with extrinsic urinary tract obstruction.
• To assess possible predictive factors for immediate technical success.
• To assess possible predictive factors for technical success at 30 days.
• To assess possible predictive factors for the evolvement of major and minor complications.
• To assess possible predictive factors for the outcome on the EQ5D questionnaire.
Study design
• Intervention
• 7 days after intervention
• 30 days after intervention
Intervention
• Retrograde placement of a double-J catheter
• Antegrade placemnet of a double-J catheter
Drs. Joanne Verdult
Haga Ziekienhuis
Leyweg 275
2545 CH Den Haag
Den Haag 2545 CH
The Netherlands
070-2100000
j.verdult@hagaziekenhuis.nl
Drs. Joanne Verdult
Haga Ziekienhuis
Leyweg 275
2545 CH Den Haag
Den Haag 2545 CH
The Netherlands
070-2100000
j.verdult@hagaziekenhuis.nl
Inclusion criteria
• Legally capable and written informed consent
• 18 years or older
• A CT or MRI diagnosis of extrinsic ureter obstruction by visible or non-visible mass surrounding the urinary tract
• Possible dorsal percutaneous approach to kidney
• Possible transvesical approach
• Possible treatment by an urologist and intervention radiologist with sufficient experience
• Patient is willing and able to comply with the specified follow-up evaluation
Exclusion criteria
• Active infection, defined as temperature >38,0 °C
• Macroscopic haematuria
• INR > 2,0
• Thrombocytes < 50 109/l
• Ileal conduit urinary diversion
• Kidney transplantation
• Horseshoe kidney
• Known allergy to contrast media
• Pregnancy
Design
Recruitment
Followed up by the following (possibly more current) registration
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL4786 |
| NTR-old | NTR4925 |
| CCMO | NL49696.098.14 |
| OMON | NL-OMON42126 |